Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
 EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation

Volume 8, Number 9, September 2002

Research

Characterization of Flagella Produced by Clinical Strains of Stenotrophomonas maltophilia

Doroti de Oliveira-Garcia,*† Monique Dall'Agnol,‡ Mónica Rosales,‡ Ana C.G.S. Azzuz,§ Marina B. Martinez,†§ and Jorge A. Girón‡
*Laboratório Clínico do Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil; †Departamento de Microbiologia do Instituto de Ciências Biomédicas da Universidade de São Paulo, São Paulo, Brazil; ‡Benemerita Universidad Autónoma de Puebla, Puebla, México; and §Departamento de Análises Clínicas da Faculdade de Ciências Farmacêuticas da Universidade de São Paulo, São Paulo, Brazil

 
 
Figure 4. Reactivity of Stenotrophomonas maltophilia flagellin with different antibodies.
  Back to article
 

Figure 4. Reactivity of Stenotrophomonas maltophilia flagellin with different antibodies. Lane 1, SMDP92 strain; lane 2, ATCC 13637. Blots containing whole cells extracts of SMDP92 and ATCC 13637 were reacted with antibodies against SMFliC, flagella of Proteus mirabilis, and anti-FlaA and anti-FlaB of Pseudomonas aeruginosa.

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed July 26, 2002

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention